T82.82
Fibrosis due to cardiac and vascular prosthetic devices, implants and grafts
Clinical Classification Guidelines
Medical Intelligence & Overview
Fibrosis related to cardiac and vascular prosthetic devices, implants, and grafts is a condition characterized by the development of excessive fibrous tissue around medical devices used in the cardiovascular system. This process can lead to stiffening or narrowing of blood vessels or heart structures, potentially impacting their function. Recognizing and understanding this condition is critical for effective management and ongoing care of affected patients.
Causes & Symptoms
Clinical Causes: Installation of prosthetic devices, such as pacemakers, defibrillators, or vascular grafts Foreign material within the cardiovascular system encouraging fibrous tissue formation Chronic inflammation or immune response to implanted devices Repeated mechanical stress or movement at the device site Poor healing response post-implantation
Key Symptoms: Swelling or induration around the implant site Reduced blood flow leading to symptoms like numbness, cold extremities, or discoloration Altered heart function in cases involving cardiac implants, possibly causing fatigue or shortness of breath Pain or discomfort near the implantation area Possible signs of infection or device malfunction
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and imaging studies. Medical professionals may utilize techniques such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), or angiography to assess the extent of fibrosis. Laboratory tests might also be performed to rule out infections or other complications. A detailed patient history about device placement and symptoms aids in identifying fibrosis as the underlying issue.
Treatment Protocols: Managing fibrosis due to prosthetic devices often includes medical and surgical approaches. Options may comprise anti-inflammatory medications to control ongoing tissue response, physical therapy to maintain mobility, or surgical interventions to remove or revise affected implants. In some cases, procedures to modify or bypass areas of fibrosis are performed to restore proper function. Close monitoring is essential to promptly address any progression or complications arising from the fibrosis.
Clinical Advice & FAQs
Billing Guidance
Is T82.82 a billable ICD-10 code?
Yes, T82.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T82.82?
Clinical documentation must specify the nature of Fibrosis due to cardiac and vascular prosthetic devices, implants and grafts and any associated comorbidities for accurate reporting.
Cite this Clinical Reference